New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
David Ridley
Senior Editor – Europe
During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.
Advertisement
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From David Ridley
Avoiding ‘Kiss Killers’ – GSK Offers German Consumers New Oral Hygiene Products For The Festival Season
With Carnival season approaching in Germany, GlaxoSmithKline is helping German consumers to take care of their oral hygiene with new toothbrushes and its Zovirax Duo cold sore treatment.
ASA Clears RB Of Misleading UK Consumers In Two Nurofen Ads
The UK's Advertising Standards Authority has cleared Reckitt Benckiser of misleading British consumers with two advertisements for its Nurofen brand of analgesics.
Lithuanian Liberalization ‘Justified,’ Says Vice-Minister of Health
A rush of retailers signing up to sell OTC medicines has suggested that Lithuania's decision to liberalize its OTC market was 'justified,' according to the country's Vice-Minister of Health Kristina Garuolienės.
Health Marketing Round-Up: January 2019
New OTC products and marketing campaigns in Germany, Australia and the UK.
NHS 10-Year Plan A ‘Missed Opportunity’, Says PAGB
The UK’s consumer healthcare industry association, the Proprietary Association of Great Britain (PAGB), says that National Health Service (NHS) England has “missed an opportunity” by not placing self-care at the center of its new ‘Long Term Plan’.
EllaOne Firm Endorses UK Reproductive Rights Group's Push For OTC Sales Of Emergency Contraceptives
EllaOne manufacturer HRA Pharma supports British Pregnancy Advisory Service's call to scrap mandatory consultations for emergency contraceptives by switching the medicines from pharmacy-only sales to OTC. BPAS says there are “no risks which outweigh its use and it is considerably safer than many medicines sold straight from the shelf in the UK."
Advertisement